United StatesBreaking News

On this episode of Stock Movers: - AutoZone (AZO) shares fall after the retailer of automotive replacement parts posted comparable sales for the third quarter that fell short of Wall Street's expectations. - Ferrari (RACE IM) shares fell almost 8% after critics panned the look of its first fully electric vehicle, a setback for the Italian super-car maker's controversial push into EVs. - Eli Lilly (LLY) agreed to buy three vaccine developers for as much as $3.8 billion, marking the drugmaker's re-entry into the infectious disease space.

Space and satellite stocks are surging as SpaceX begins its IPO roadshow. Elon Musk's company filed last week for what stands to be the biggest initial public offering ever. On Friday, the company's Starship launched and successfully deployed mock satellites before returning to Earth safely. Bloomberg's Ed Ludlow reports.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) released updated Phase 1/2 clinical data for its experimental antibody-drug conjugate, CRB-701, demonstrating therapeutic activity in patients with pretreated, human papillomavirus (HPV)-associated solid tumors that express high levels of the Nectin-4 protein.

UBS raised its price target on Micron to a Street-high view of $1,625, up from $535. Mandeep Singh has more on "Bloomberg Open Interest."

Performance Shipping (NASDAQ:PSHG) reported a 59% increase in first-quarter revenue for 2026, driven by a larger operational fleet and stronger charter rates that accelerated the company's operating cash generation.

Dyne Therapeutics (NASDAQ:DYN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking conditional marketing clearance for z-rostudirsen, its investigational treatment targeting a specific subset of patients with Duchenne muscular dystrophy (DMD).

Gregory Daco, EY-Parthenon chief economist, says he thinks former Federal Reserve Chair Jerome Powell will not be afraid to dissent as a member of the board of governors. Daco speaks on "Bloomberg Surveillance."

Virax Biolabs Group (NASDAQ:VRAX) announced positive preliminary performance metrics from an early pilot dataset for ViraxImmune™, its proprietary blood-based diagnostic test under development for Long COVID and related post-acute infection syndromes (PAIS).

Uni-Fuels Holdings (NASDAQ:UFG) raised its full-year revenue guidance after reporting sharp top-line expansion and volume growth for the first quarter of 2026, driven by a broad scale-up in global marine fuel trading and commercial market capture.

Bill Dudley, former New York Fed President and Bloomberg Opinion columnist, examines the effectiveness of Federal Reserve policy and the central bank's credibility on inflation. His opinions are his own.

CSW Industrials (NYSE:CSW) reported record financial results for both the fourth quarter and the full fiscal year of 2026, navigating higher interest expenses and non-cash charges through a combination of aggressive acquisition integration and a return to organic expansion in its core segment.

Freightos (NASDAQ:CRGO) reported mixed financial and operational metrics for the first quarter of 2026, as geopolitical tensions and airspace restrictions across the Middle East slowed core transaction growth while simultaneously driving up global shipping rates to support the logistics platform's overall transaction value.